In reference to earlier intimation dated August 15, 2024, with respect to Intimation of Restoration of Corporate Insolvency Resolution Process (‘CIRP’) vide order dated August 14, 2024 passed by the National Company Law Tribunal (‘NCLT’) against the Company and pursuant to the Regulation 30 and 47 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Cian Healthcare has informed that it enclosed copies of newspaper publication, published in Business Standard (English Edition) and Navrashtra (Marathi Edition) on November 27, 2025, with respect to the Corrigendum to 22nd Annual General Meeting (‘AGM’) of the Members of the company scheduled to be held on Wednesday, December 17, 2025 at 10:00 am through Video Conferencing (‘VC’) / Other Audio Visual Means (‘OAVM’).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: